VERAXA Biotech Lists on Nasdaq via SPAC Merger
The cancer-therapy developer completes its SPAC deal with Voyager Acquisition Corp., marking one of the few biotech lis…
The cancer-therapy developer completes its SPAC deal with Voyager Acquisition Corp., marking one of the few biotech lis…
The Texas wine educator argues that structured consumer dialogue at tasting rooms builds brand loyalty and repeat visit…
At $4.99 per bottle and three servings per unit, the New York RTD brand is targeting value-driven drinkers priced out o…
The Grapevine-based digital publisher adds beverage-education content as U.S. wine producers lean harder on direct cons…
The French processed-foods producer joins a wave of European consumer-staples companies returning capital to shareholde…
The Baltic seafood group exits its SKT subsidiary as shareholder loans and inventory financing transfer to the Latvian …
Shareholder approval secured in May; deferred payment terms govern the outstanding purchase price and transferred inven…
Phase 3 data for lead asset ecopipam published in JAMA Neurology; regulatory submission targeted for second half of 202…
The Lithuanian dairy group's management files a regulatory securities transaction report, triggering standard exchange …
The Lithuanian dairy group notified markets of trades in its own stock by senior insiders, fulfilling mandatory disclos…
The Fort Lauderdale deal adds strategically positioned industrial capacity in one of the fastest-growing F&B logistics …
The promotion runs June 11–July 19, targeting summer foot traffic at Hudson Yards as Spanish wine producers push U.S. o…